Hepatocellular Carcinoma in Pakistan: Where do We Stand?

Author(s):
Amna Subhan ButtAmna Subhan Butt1,*, Zaigham AbbasZaigham Abbas1, Wasim JafriWasim Jafri1
1Section of Gastroenterology, Department of Medicine, The Aga Khan University Hospital, [email protected], 74800, Pakistan

Hepatitis Monthly:Vol. 12, issue 10; 6023
Published online:Oct 10, 2012
Article type:Review Article
Received:Nov 29, 2011
Accepted:Apr 05, 2012
How to Cite:Butt A, Abbas Z, Jafri W. Hepatocellular Carcinoma in Pakistan: Where do We Stand?. Hepat Mon. 2012;12(10):6023. doi: https://doi.org/10.5812/hepatmon.6023

Abstract

Context:

From the 1970s till the mid 1990s, hepatitis B was the most common etiological factor for hepatocellular carcinoma (HCC) in Pakistan. Afterwards, a shift in HCC etiology was observed with a steady rise in hepatitis C virus (HCV) related HCC cases. HCV-3a, which is the most prevalent genotype, is also most frequent in HCV related HCC. There was an increase in the proportion of non-B non-C (NBNC) HCC cases as well, which might be attributed to an increase in non-alcoholic fatty liver disease.

Evidence Acquisition:

The age-standardized rate for HCC is 7.64/100 000 in males and 2.8/100 000 in females. Male to female ratio is 3.6:1. Usual age of presentation is in the fifth and sixth decade. Most patients present with advanced disease, as they are not in a regular surveillance program. This is more so for patients with NBNC chronic liver disease. As many sonologists in Pakistan are practicing without sufficient training to pick up early lesions, alpha-fetoprotein is still recommended to compliment ultrasound in the surveillance of HCC.

Results:

Majority of HCC patients present with nonresectable disease. Interventions such as transarterial chemoembolization, radiofrequency ablation, resection and chemotherapy including sorafenib are available in selected centers. Pakistan appears to be in an area of intermediate endemicity for HCC. There is a need for population based epidemiological studies to estimate the exact disease burden.

Conclusions:

Measures to prevent the spread of hepatitis C and B can slow down the epidemic rise in the incidence of HCC in the coming decades. There is a need to implement a proper surveillance program to identify HCC cases at an early stage.

Full Text

Full text is available in PDF

Similar Articles

30
Sep
2010

Hepatitis C in Pakistan: A Review of Available Data

Hamama Bushra,
Masood Ahmad,
Muhammad Khurram,
Saima Usman,
Mohammad Arif,
Tashfeen Adam
,et al.

Bushra H, Ahmad M, Khurram M, Usman S, Arif M, et al. Hepatitis C in Pakistan: A Review of Available Data. Hepat Mon. 2010;10(3):. doi:

18
Mar
2019
86428

Molecular Epidemiology of Hepatitis C Virus Genotypes Among Chronically Infected Patients in Pakistan

Shahroz Khan,
Ijaz Ali,
Malik Badshah,
Qaiser Mohammad Khan,
Zahida Nasreen Haider,
Sajid Ali
,et al.

Khan S, Ali I, Badshah M, Khan QM, Haider ZN, et al. Molecular Epidemiology of Hepatitis C Virus Genotypes Among Chronically Infected Patients in Pakistan. Jundishapur J Microbiol. 2019;12(3):e86428. doi: https://doi.org/10.5812/jjm.86428

11
Oct
2014

Geographic Distribution of Hepatitis C Virus Genotypes in Pakistan

Nasar Khan,
Muhammad Akmal,
Muhammad Hayat,
Muhammad Umar,
Atta Ullah,
Iqbal Ahmed
,et al.

Khan N, Akmal M, Hayat M, Umar M, Ullah A, et al. Geographic Distribution of Hepatitis C Virus Genotypes in Pakistan. Hepat Mon. 2014;14(10):e20299. doi: https://doi.org/10.5812/hepatmon.20299

12
Apr
2017

Diagnosis and Staging of Hepatocellular Carcinoma

Amir H Davarpanah

Davarpanah AH. Diagnosis and Staging of Hepatocellular Carcinoma. I J Radiol. 2017;14(Special Issue):e48398. doi: https://doi.org/10.5812/iranjradiol.48398

30
Oct
2012

Viral Hepatitis Induces Hepatocellular Cancer: What Can We Learn from Epidemiology Comparing Iran and Worldwide Findings?

Elisabeth Smolle,
Evelyn Zhrer,
Kira Bettermann,
Johannes Haybaeck

Smolle E, Zhrer E, Bettermann K, Haybaeck J. Viral Hepatitis Induces Hepatocellular Cancer: What Can We Learn from Epidemiology Comparing Iran and Worldwide Findings?. Hepat Mon. 2012;12(10):7879. doi: https://doi.org/10.5812/hepatmon.7879


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC